Skip to main content
editorial
. 2019 Dec 16;29:e79. doi: 10.1017/S2045796019000751

Fig. 2.

Fig. 2.

Acceptability of esketamine v. placebo at day 28 (study endpoint), measured as drop-outs due to any cause.